Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Precancerous Conditions 1Papillomavirus Infections 1Papilloma 1HIV Infections 1Condylomata Acuminata 1Acquired Immunodeficiency Syndrome 1AIDS-Related Opportunistic Infections 1AIDS-Related Complex 1

Interventions

Papillomavirus Vaccines 5human papillomavirus vaccine, L1 type 16, 18 2Vaccines 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2halofantrine 1fludarabine 1VGX-3100 1Radiotherapy 1Polymerase Chain Reaction 1Interleukin-2 1Interferon alpha-2 1Cyclophosphamide 1Cidofovir 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Papillomavirus Infections × Cidofovir × Clear all
NCT00811408 2010-01-28

Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

National Cancer Institute (NCI)

Phase 1 Unknown
24 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡